(Medical Xpress)—Pulmonary surfactants are phospholipoproteins (surface-active lipoprotein complexes) that reduces alveolar surface tension through an air-water hydrophilic/hydrophobic interface. Pulmonary, or lung, surfactants ...
Researchers led by the University of Toronto, Canada, have conducted a randomized clinical trial to evaluate the effectiveness of enhanced vs. minimal nasal suctioning in treating infants with bronchiolitis after discharge ...
Promising trial results indicate that a new type of cell therapy could improve the prognosis of those who are critically ill with acute respiratory distress syndrome (ARDS) resulting from severe COVID-19.
Feb 6, 2024
0
63
New UCLA-led research finds that infants born full term to mothers who were infected with COVID-19 during pregnancy had three times the risk of having respiratory distress compared with unexposed infants, even though they ...
Jan 24, 2024
0
129
Cytokines are chemical messengers that help the body get rid of invading bacteria and viruses, and control inflammation. The body carefully balances cytokines because they help keep the immune system healthy. However, this ...
Jan 17, 2024
0
54
Blood clotting (thrombosis) in the capillary vessels of the lungs is one of the first consequences of severe COVID-19, even preceding the respiratory distress caused by diffuse alveolar damage, according to a Brazilian study ...
Dec 8, 2023
0
96
In a study published in the New England Journal of Medicine, clinicians and researchers from the CHU of Liège and the University of Liège show that the administration of plasma taken from convalescent donors after infection ...
Oct 25, 2023
0
20
A synthetic peptide developed by researchers at the Medical College of Georgia could help reduce vascular problems associated with acute respiratory distress syndrome (ARDS) in COVID-19.
Oct 3, 2023
0
23
Researchers from the University of Pittsburgh and the National Institutes of Health (NIH) Vaccine Research Center have developed an improved way to test potential vaccines against bird flu. The report was published this week ...
Sep 29, 2023
0
29
A cancer drug could play an important role in limiting the damaging effects of lung disease in COVID-19 patients, thanks to new research at Hudson Institute of Medical Research.
Sep 18, 2023
0
29
